Max Planck Florida Institute for Neuroscience

Contact
maxplanckflorida.org

Max Planck Florida Institute for Neuroscience

1 Max Planck Way
33458 Jupiter
USA
maxplanckflorida.org
Contact
Profile News
Contact

About Max Planck Florida Institute for Neuroscience

The Jupiter Neuroscience Campus consists of collaboration between neuroscientists from MPFI, Scripps Florida, and Florida Atlantic University, with an extended network of research excellence in nearby Torrey Pines Institute for Molecular Studies. Faculty, investigators, and students regularly organize seminars, poster sessions, training activities, symposia, and networking events to help foster collaborative exchange of scientific ideas and to increase exposure and opportunities for scientists and students.

Read more about Max Planck Florida Institute for Neuroscience
Facts about Max Planck Florida Institute for Neuroscience
  • Industry : Biology

News about Max Planck Florida Institute for Neuroscience

Max Planck Florida Institute for Neuroscience

04-Dec-2015 | science

New research sheds light on neuronal communication

Neurons communicate with each other through specialized structures called synapses. The information is transmitted in the form of synaptic vesicles that ...

Read news
Show more news about Max Planck Florida Institute for Neuroscience

Here you will find Max Planck Florida Institute for Neuroscience

Last viewed contents

List_of_hesperiid_genera:H

Go to page

List_of_ichthyosaurs

Go to page

Europe to tackle brain disorder research by linking industry, academia - Brain disorders including addiction, depression, and schizophrenia afflict 1 billion people and are often incurable with current therapies

Go to page

List_of_geometrid_genera:_I

Go to page

List_of_gelechiid_genera

Go to page

Sanofi-aventis and Oxford Biomedica report encouraging TroVax Phase II results in metastatic renal cancer

Go to page

List_of_hesperiid_genera:F

Go to page

List_of_arctiid_genera:_O

Go to page

List_of_geometrid_genera:_E

Go to page

Eiken Chemical Co., Ltd. and bioMérieux Enter into Business Collaboration for Pre-Poured Media

Go to page

Lonza announced the expansion of its peptides manufacturing capacities

Go to page

Significant Percentage of MS Patients Receiving Alemtuzumab in Genzyme’s Phase 2 Trial Remain Free of Clinically-Active Disease

Go to page